HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional)
ID: 356298Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $375K

Eligible Applicants

Others

Funding Category

Income Security and Social Services

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/356298

Additional Information

http://grants.nih.gov/grants/guide/rfa-files/RFA-AT-25-001.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering the HEAL Initiative: Pain Research Enhancement Program (PREP), a federal grant aimed at supporting pain research projects from R15-eligible institutions. This initiative seeks to promote rigorous basic and mechanistic pain research, foster interdisciplinary collaborations, and enhance the research environment for health professional trainees and students. The program is crucial for diversifying the pain research workforce and advancing understanding of pain mechanisms, with funding available up to $375,000 over a maximum three-year period. Applications will be accepted starting October 18, 2024, with a deadline of November 19, 2024, and interested applicants can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    RFA-AT-25-001-Full-Announcement.html
    RFA-AT-25-001.html
    The Department of Health and Human Services, through the NIH, announces the HEAL Initiative: Pain Research Enhancement Program (PREP) aimed at funding pain research from R15-eligible institutions. The program emphasizes supporting basic pain research, fostering interdisciplinary partnerships, and enhancing research environments for students in health professions. Applicants can request up to $375,000 over a maximum three-year period, with no more than a third of the total project cost allocated to non-R15 institutions. The application requires a strong research plan, a Team Management Plan detailing partnerships, and a Facilities & Other Resources document to involve students actively in research. Key objectives include creating small-scale mechanistic studies on pain, promoting new research collaborations, and engaging students in hands-on research experiences. The initiative aims to diversify the pain research workforce and can accept clinical trial proposals, focusing on understanding pain mechanisms rather than evaluating interventions’ efficacy. Successful applications should incorporate a Plan for Enhancing Diverse Perspectives (PEDP) and demonstrate rigorous methodologies in their research strategies. The program aligns with NIH's goals to enhance pain management and opioid addiction treatment, fostering a diverse and effective research community. Applications will be accepted starting October 18, 2024, with a deadline of November 19, 2024, among others through 2025-2026.
    Similar Opportunities
    HEAL Initiative: Interdisciplinary Team Science to Uncover the Mechanisms of Pain Relief by Medical Devices (RM1 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "HEAL Initiative: Interdisciplinary Team Science to Uncover the Mechanisms of Pain Relief by Medical Devices," aimed at addressing the opioid epidemic by promoting innovative research into alternative pain management solutions. This initiative seeks interdisciplinary research teams composed of multiple Principal Investigators (PDs/PIs) to explore the mechanisms of action of FDA-approved medical devices designed for pain relief, with the goal of optimizing therapeutic outcomes and enhancing understanding of device-based therapies. With over 25 million Americans suffering from chronic pain, this funding is critical for developing safe and effective pain treatment options that minimize addiction risks. Interested applicants can apply for grants with an award ceiling of $1.5 million, and proposals are due by June 9, 2025. For further inquiries, applicants may contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-23-028.html.
    HEAL Initiative: Understanding Individual Differences in Human Pain Conditions (R01 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity under the HEAL Initiative aimed at understanding individual differences in human pain conditions through the R01 grant mechanism. This initiative seeks research proposals that focus on the holistic understanding of pain variability among individuals, emphasizing the collection of clinical and preclinical data to inform personalized pain management strategies. The program is particularly relevant in the context of addressing the ongoing opioid crisis and aims to foster innovative, evidence-based solutions for pain treatment by encouraging multidisciplinary approaches and patient engagement. Approximately $4 million is available to support 3-4 awards, with applications due by February 6, 2025. Interested applicants can find more information and application guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    HEAL Initiative: Understanding Individual Differences in Human Pain Conditions (R01 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity under the HEAL Initiative, aimed at understanding individual differences in human pain conditions through the R01 grant mechanism. This initiative seeks to support research that holistically examines inter-individual differences in pain experiences, focusing on personalized pain management strategies and the collection of clinical and preclinical data. The funding is particularly important for advancing knowledge on the biological and psychosocial factors influencing pain sensitivity and treatment responses, especially in underserved populations. NIH plans to allocate approximately $4 million for 3-4 awards, with each application eligible for up to $650,000 in direct costs over a five-year period. Interested applicants must submit their proposals by February 6, 2025, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggable Proteome (R03 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the HEAL Initiative's funding opportunity titled "Early-Stage Discovery of New Pain Targets Within the Understudied Druggable Proteome (R03 Clinical Trial Not Allowed)." This initiative aims to support pilot projects that identify new druggable targets for pain by generating preliminary data on understudied proteins associated with pain management. The funding opportunity is particularly significant as it seeks to advance research in pain management and drug discovery, contributing to the broader goal of addressing the opioid addiction crisis. Eligible applicants can receive up to $100,000 for projects lasting one year, with applications due by July 16, 2026. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-24-197.html.
    HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the HEAL Initiative aimed at supporting research for non-opioid analgesics via the R61/R33 Exploratory/Developmental Phased Award. This initiative encourages applications that focus on the early translational steps in developing novel pain treatment strategies, including the development and validation of assays and the identification of potential therapeutic agents, while explicitly prohibiting clinical trials. The funding amount is up to $350,000 per year, with a total project period not exceeding three years, and applications are due by January 15, 2027. Interested applicants can find more information and application guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity under the HEAL Initiative, titled "Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)." This initiative aims to support early-stage translational research focused on developing and validating tests for non-opioid analgesics, including small molecules and biologics, to address the ongoing opioid crisis and improve pain management. The program anticipates a funding pool of $2.5 million, with plans to award approximately 4-5 grants in FY 2025, and applications are due by January 15, 2027. Interested applicants can find more information and application details at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    NIH HEAL Initiative: Coordinated Approaches to Pain Care in Health Care Systems (UG3/UH3 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity under the HEAL Initiative for the implementation of coordinated pain care models within healthcare systems that currently lack such frameworks. This initiative encourages applications for UG3/UH3 phased cooperative agreements that utilize implementation science to enhance multidisciplinary chronic pain management, particularly focusing on populations with significant health disparities. The program aims to foster structured collaborations among healthcare providers, patients, and policymakers to improve access to comprehensive care, with an expected budget of approximately $4 million to fund 3 to 5 projects. Interested applicants must submit their proposals by November 8, 2024, and can find additional information and submission guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    HEAL Initiative: Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity under the HEAL Initiative aimed at discovering and validating novel therapeutic targets for safe and effective pain treatment through the R01 Clinical Trial Not Allowed grant. This initiative seeks proposals that focus on basic science research targeting the peripheral nervous system, central nervous system, and other tissues, with an emphasis on developing pain therapeutics that minimize side effects and addiction risks. The NIH plans to award 8-10 grants, with project durations of up to five years, addressing various pain conditions including acute and chronic pain syndromes, amidst the ongoing opioid crisis. Interested applicants must submit their proposals by December 6, 2024, and can find additional information and submission guidelines at the provided NIH link or contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
    HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management," aimed at addressing the national opioid public health crisis. This initiative encourages small businesses to develop innovative, non-addictive therapies and technologies for improved pain management, including new medications, pain-assessment devices, and treatment strategies for chronic pain. The funding available includes up to $275,766 for Phase I and $1,838,436 for Phase II grants, with applications due by April 4, 2025. Interested applicants can find more information and guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    HEAL Initiative: HEAL KIDS (Knowledge, Innovation and Discovery Studies): Chronic Pain Program (UC2 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity under the HEAL Initiative, specifically targeting chronic pain in children and adolescents through the HEAL KIDS Chronic Pain Program. This program invites interdisciplinary research teams to conduct innovative studies that integrate clinical research, advanced technologies, and measurement science to enhance understanding and management of chronic pain conditions in youth. The initiative emphasizes the importance of diversity in research, requiring applicants to submit a Plan for Enhancing Diverse Perspectives, and aims to improve pediatric pain management and facilitate clinical trials. Approximately $5 million is available for 2-3 awards, with a maximum annual budget of $1.3 million over a five-year project period. Interested applicants must submit their proposals by November 8, 2024, and can find additional information at NIH Grants or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.